Perrigo Company plc (NYSE:PRGO – Get Free Report) CFO Eduardo Guarita Bezerra acquired 5,000 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was purchased at an average cost of $29.18 per share, for a total transaction of $145,900.00. Following the completion of the transaction, the chief financial officer now owns 8,428 shares in the company, valued at approximately $245,929.04. The purchase was disclosed in a document filed with the SEC, which is available at this link.
Perrigo Price Performance
Shares of NYSE:PRGO opened at $30.38 on Thursday. The company has a debt-to-equity ratio of 0.85, a current ratio of 2.74 and a quick ratio of 1.60. Perrigo Company plc has a 12 month low of $26.81 and a 12 month high of $40.28. The firm has a market capitalization of $4.12 billion, a P/E ratio of 607.72 and a beta of 0.87. The company’s fifty day moving average price is $30.58 and its 200 day moving average price is $33.46.
Perrigo (NYSE:PRGO – Get Free Report) last posted its earnings results on Tuesday, November 7th. The company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.61 by $0.03. The business had revenue of $1.12 billion during the quarter, compared to the consensus estimate of $1.20 billion. Perrigo had a return on equity of 6.98% and a net margin of 0.15%. The business’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.56 EPS. As a group, sell-side analysts predict that Perrigo Company plc will post 2.55 earnings per share for the current fiscal year.
Perrigo Dividend Announcement
Wall Street Analyst Weigh In
PRGO has been the topic of several recent analyst reports. StockNews.com lowered Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday. JPMorgan Chase & Co. raised their target price on Perrigo from $45.00 to $48.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 9th.
View Our Latest Research Report on Perrigo
Institutional Trading of Perrigo
Institutional investors and hedge funds have recently bought and sold shares of the business. CWM LLC increased its stake in Perrigo by 73.0% in the first quarter. CWM LLC now owns 699 shares of the company’s stock valued at $25,000 after purchasing an additional 295 shares during the period. Dark Forest Capital Management LP purchased a new stake in Perrigo during the 1st quarter valued at approximately $31,000. Ronald Blue Trust Inc. raised its stake in Perrigo by 132.3% during the 3rd quarter. Ronald Blue Trust Inc. now owns 1,157 shares of the company’s stock valued at $39,000 after acquiring an additional 659 shares during the last quarter. Parallel Advisors LLC grew its stake in shares of Perrigo by 434.8% in the 1st quarter. Parallel Advisors LLC now owns 1,214 shares of the company’s stock valued at $44,000 after purchasing an additional 987 shares during the last quarter. Finally, NewEdge Advisors LLC grew its stake in shares of Perrigo by 345.5% in the 1st quarter. NewEdge Advisors LLC now owns 1,430 shares of the company’s stock valued at $51,000 after purchasing an additional 1,109 shares during the last quarter. Hedge funds and other institutional investors own 95.74% of the company’s stock.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in Ireland, the United States, France, Belgium, China, the United Kingdom, Germany, Switzerland, Austria, Italy, Australia, Greece, and Spain. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments.
Featured Articles
- Five stocks we like better than Perrigo
- Video Game Stocks: How to Invest in Gaming
- Is it time to buy the dip in Walmart shares?
- 3 Warren Buffett Stocks to Buy Now
- Unlocking AI investment opportunities in healthcare
- What Are Dividends? Buy the Best Dividend Stocks
- New Disney investor propels stock to ranks of best S&P gainers
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.